Literature DB >> 1903709

Human antibody production in transgenic mice: expression from 100 kb of the human IgH locus.

M Brüggemann1, C Spicer, L Buluwela, I Rosewell, S Barton, M A Surani, T H Rabbitts.   

Abstract

In order to study the requirements for a human antibody repertoire to be engineered in transgenic animals, we have created mouse strains that express human immunoglobulin genes from 100 kb of cosmid DNA. Undisrupted integration of the human DNA in the mouse germ line, encoding germ-line V,D,J and the Cmu constant region, was achieved, and proved sufficient for the production of human IgM in the mouse serum. Co-integration of one cosmid (containing the VH6 gene and a 36-kb region of the J-proximal D cluster) with a second cosmid (containing VH26, a further 38-kb of the D cluster, JH and Cmu) results in V-D-J rearrangements in the transgenic mice, similar to those seen in human DNA, were found only in spleen but not in thymus. Random hybridomas made from these transgenic mice show heterogeneous rearrangements of the human transgenes. Sequences of V-D-J units derived from transgene rearrangements reveal extensive N-region and apparent D segment diversity. These results show that utilisation of human Ig genomic segments does occur in transgenic mice, paving the way for the derivation of a mouse strain that makes authentic human antibodies from inserted heavy and light chain gene loci.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903709     DOI: 10.1002/eji.1830210535

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

Review 2.  Recombinant antibodies for the diagnosis and treatment of cancer.

Authors:  Jürgen Krauss
Journal:  Mol Biotechnol       Date:  2003-09       Impact factor: 2.695

3.  Chimaeric monoclonal antibodies encoded by the human VH26 gene from naïve transgenic mice display a wide range of antigen-binding specificities.

Authors:  I J Harmer; R A Mageed; A Kaminski; P Charles; M Brüggemann; C G Mackworth-Young
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

4.  Rearrangement of the human heavy chain variable region gene V3-23 in transgenic mice generates antibodies reactive with a range of antigens on the basis of VHCDR3 and residues intrinsic to the heavy chain variable region.

Authors:  R A Mageed; I J Harmer; S L Wynn; S P Moyes; B B Maziak; M Brüggemann; C G MacKworth-Young
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

5.  Deglycosylation of mAb by EndoS for improved molecular imaging.

Authors:  Peng Gao; Kenneth L Pinkston; Nathaniel Wilganowski; Holly Robinson; Ali Azhdarinia; Banghe Zhu; Eva M Sevick-Muraca; Barrett R Harvey
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

6.  Antibodies generated from human immunoglobulin miniloci in transgenic mice.

Authors:  S D Wagner; G T Williams; T Larson; M S Neuberger; D Kitamura; K Rajewsky; J Xian; M Brüggemann
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

Review 7.  Novel antibodies targeting immune regulatory checkpoints for cancer therapy.

Authors:  Chern Siang Lee; Mark Cragg; Martin Glennie; Peter Johnson
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

8.  A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins.

Authors:  L D Taylor; C E Carmack; S R Schramm; R Mashayekh; K M Higgins; C C Kuo; C Woodhouse; R M Kay; N Lonberg
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

9.  Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts.

Authors:  N Tuaillon; L D Taylor; N Lonberg; P W Tucker; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  The role of antigen in the selection of the human V3-23 immunoglobulin heavy chain variable region gene.

Authors:  C G Mackworth-Young; I J Harmer; R A Mageed
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.